A Role for <i>Smoothened</i> during Murine Lens and Cornea Development by Janet J. Y. Choi (636307)

“…Mutant lenses were smaller and showed normal expression of p57Kip2, c-Maf, E-cadherin and Pax6, reduced expression of FoxE3 and Ptch1 and decreased nuclear Hes1. There was normal G1-S phase but decreased G2-M phase transition at E16.5 and epithelial cell death from E14.5-E16.5. …”

Flowchart of in- and exclusion. by Patrick Ristau (13794436)

Subjects:

Dataset definition of minimal underlying data. by Patrick Ristau (13794436)

Subjects:

Survival at hospital discharge. by Patrick Ristau (13794436)

Subjects:

Baseline characteristics, initial management, and outcome of OHCA. by Patrick Ristau (13794436)

Subjects:

Median response time. by Patrick Ristau (13794436)

Subjects:

Minimal underlying dataset. by Patrick Ristau (13794436)

Subjects:

Endline data availability and patient sample sizes by HealthRise site and for intervention and comparison patients. by Nancy Fullman (243628)

Summary of key themes, components, and quotes from qualitative data synthesized across US HealthRise sites. by Nancy Fullman (243628)

Unadjusted and adjusted difference-in-difference regression results, by HealthRise grantee, for hypertension (A) and diabetes (B) patients. by Nancy Fullman (243628)

Percentage of HealthRise patients meeting hypertension and diabetes disease severity categories between baseline and endline, by site. by Nancy Fullman (243628)

Baseline and endline measures by HealthRise site and for intervention and comparison patients for hypertension (A) and diabetes (B). by Nancy Fullman (243628)

Overview of interventions by US HealthRise site. by Nancy Fullman (243628)

Li₃V(MoO₄)₃: A New Material for Both Li Extraction and Insertion by D. Mikhailova (2122621)

“…In situ synchrotron diffraction on a Li_<i>x</i>V(MoO₄)₃ cathode with <i>x</i> ≈ 3 during the first discharge/charge cycle revealed a monotonous increase of the lattice volume and of the lattice parameter <i>a</i> during Li insertion from <i>x</i> = 3 to <i>x</i> = 3.5, but a multiphase mechanism for 3.5 ≤ <i>x</i> ≤ 4. …”

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant by Yingxia Wen (2455015)

“…Also, bivalent proteins (A244.AE and 6240.B) formulated with MF59 elicited distinct V2-specific Abs to the epitope previously shown to correlate with decreased risk of HIV-1 infection in the RV144 trial. …”

Data_Sheet_5_Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.PDF by Shin-ichiro Hattori (5767388)

<i>tho2</i> and <i>hpr1</i> selectively decrease the expression level of Rif1p. by Tai-Yuan Yu (328952)

“…<p>(<b>A</b>) The Rif1p protein level is decreased in <i>tho2</i> and <i>hpr1</i> cells. …”

Spike-in normalization reveals the expected H3K27me3 decrease following EZH2 inhibition. by Brian Egan (3359225)

“…<p><b>(A)</b> IGV browser image of spike-in normalized H3K27me3 ChIP-seq data from cells treated for 4 and 8 days with CPI-360. …”

The B-Raf^V600E-Twist axis regulates miR-10b expression in melanoma. by Ila Datar (433874)

Fatty acid composition (%) of <i>H</i>. <i>aurantium</i> tunic lipids. by A-yeong Jang (9500111)